Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H34N2O4 |
InChIKeyJBBCDNNDYGLMOE-LZITZJIASA-N |
CAS Registry1619983-52-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 01 Apr 2020 |